Pyrazolidine derivatives with heteroaryl urea as dipeptidyl peptidase IV inhibitors

Chemical and Pharmaceutical Bulletin

Volumn 53, Issue 8, 2005, Pages 1048-1050

  Ahn, Jin Hee ^a   Jung, Sun Ho ^a   Kim, Jin Ah ^a   Song, Seog Beom ^c   Kwon, Soon Ji ^c   Kim, Kwang Rok ^a   Rhee, Sang Dal ^a   Park, Sung Dae ^b   Lee, Jae Mok ^c   Kim, Sung Soo ^a   Cheon, Hyae Gyeong ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Jeil Pharmaceutical Co Ltd   (South Korea)

^c CJ Corporation   (South Korea)

Author keywords

Anti diabetic agent; Dipeptidyl peptidase IV (DP IV); Pyrazolidine

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; PYRIDINE DERIVATIVE; UREA DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; MOUSE; NONHUMAN;

ANIMALS; ANTIGENS, CD26; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; PROTEASE INHIBITORS; PYRAZOLES;

EID: 24944548675     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.53.1048     Document Type: Article

References (19)

1. Mentlein R., Regul. Pept., 85, 9-24 (1999).
2. Mentlein R., Gallwitz B., Schmidt W. E., Eur. J. Biochem., 214, 829-835 (1993).
3. Kieffer T. J., McIntosh C. H. S., Pederson R. A., Endocrinology, 136, 3585-3596 (1995).
4. For a review, see: Rosenblum J. S., Kozarich J. W., Current Opinion in Chemical Biology, 7, 496-504 (2003).
5. Drucker D. J., Diabetes, 47, 159-169 (1998).
6. Deacon C. F., Hughes T. E., Holst J. J., Diabetes, 47, 764-769 (1998).
7. Pederson R. P., White H. A., Schlenzig D., Pauly R. P., McIntosh C. R. P., Demuth H. U., Diabetes, 47, 1253-1258 (1998).
8. For a review, see Wiedeman P. E., Trevilyan J. M., Current Opinion in Investigational Drugs, 4, 412-420 (2003).
9. Peters J. U., Weber S., Kritter S., Weiss P., Wallier A., Boehringer M., Hennig M., Kuhn B., Loeffler B. M., Bioorg. Med. Chem. Lett., 14, 1491-1493 (2004).
10. Caldwell C. G., Chen P., He J., Parmee E. R., Leiting B., Marsilio F., Patel R. A., Wu J. K., Eiermann G. J., Petrov A., He H., Lyons K. A., Thornberry N. A., Weber A. E., Bioorg. Med. Chem. Lett., 14, 1265-1268 (2004).
11. Ashton W. T., Dong H., Sisco R. M., Doss G. A., Leiting B., Patel R. A., Wu J. K., Marsilio F., Thornberry N. A., Weber A. E., Bioorg. Med. Chem. Lett., 14, 859-863 (2004).
12. Parmee E. R., He J., Mastracchio A., Edmondson S. D., Colwell L., Eiermann G., Feeney W. P., Habulihaz B., He H., Kilburn R., Leiting B., Lyons K., Marsilio F., Patel R. A., Petrov A., Di Salvo J., Wu J. K., Thornberry N. A., Weber A. E., Bioorg. Med. Chem. Lett., 14, 43-46 (2004).
13. Magnin D. R., Robl J. A., Sulsky R. B., Augeri D. J., Huang Y., Simpkins L. M., Taunk P. C., Betebenner D. A., Robertson J. G., Abboa-Offei B. E., Wang A., Cap M., Xin L., Tao L., Sitkoff D. F., Malley M. F., Gougoutas J. Z., Khanna A., Huang Q., Han S.-P., Parker R. A., Hamann L. G., J. Med. Chem., 47, 2587-2598 (2004).
14. Kim D., Wang L., Beconi M., Eiermann G. J., Fisher M. H., He H., Hickey G. J., Kowalchick J. E., Leiting B., Lyons K., Marsilio F., McCann M. E., Patel R. A., Petrov A., Scapin G., Patel S. B., Roy R. S., Wu J. K., Wyvratt M. J., Zhang B. B., Zhu L., Thornberry N. A., Weber A. E., J. Med. Chem., 48, 141-151 (2005).
15. Ahn J. H., Kim J. A., Kim H. M., Kwon H. M., Huh S. C., Rhee S. D., Kim K. R., Yang S. D., Park S. D., Lee J. M., Kim S. S., Cheon H. G., Bioorg. Med. Chem. Lett., 15, 1337-1340 (2005).
16. Ahn J. H., Kim H.-M., Jung S. H., Kang S. K., Kim K. R., Rhee S. D., Yang S.-D., Cheon H. G., Kim S. S., Bioorg. Med. Chem. Lett., 14, 4461-4465 (2004).
17. Villhauer E. B., Brinkman J. A., Naderi G. B., Burkey B. F., Dunning B. E., Prasad K., Mangold B. L., Russell M. E., Hughes T. E., J. Med. Chem., 46, 2774-2789 (2003).
18. Balkan B., Kwasnik L., Milserendino R., Holst J. J., Diabetologia, 42, 1324-1331 (2003).
19. Sorbera L. A., Revel L., Castaner J., Drugs Future, 26, 859-864 (2001).